Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2016

Open Access 01-12-2016 | Research article

Investigation of the clinical utility of the hypomania checklist 32 (HCL-32) for the screening of bipolar disorders in the non-clinical adult population

Authors: Kounseok Lee, Hyeji Oh, Eun-Ho Lee, Joo Hyun Kim, Ji-Hae Kim, Kyung Sue Hong

Published in: BMC Psychiatry | Issue 1/2016

Login to get access

Abstract

Background

The hypomania checklist-32 (HCL-32) is a widely used questionnaire developed for identifying hypomanic components in patients with a depressive episode. Measuring and screening previous hypomanic symptoms in individuals without any definite history of depressive episode would also be needed for early detection of bipolar disorders (BDs). This study aimed at testing the clinical utility of the HCL-32 for screening of BDs in the non-clinical population.

Methods

Lifetime history of hypomanic symptoms was evaluated by using the HCL-32 in 220 patients with BDs and 313 non-clinical individuals. Sensitivity, specificity, and the area under the curve (AUC) of the Receiver Operating Characteristic (ROC) were evaluated for assessing the discriminatory power of the scale and its two sub-domains in screening BDs.

Results

The mean HCL-32 total score was significantly higher in the Bipolar II disorder group compared to the non-clinical group (P < 0.001). Most of the items (10/12) of the irritable/risk-taking factor showed higher positive responses in patient groups. Items of active/elated factor showed mixed results. The HCL-32 total score and the active/elated factor score were not adequate for both BDs and its subgroups with AUC values of less than 0.7. The irritable/risk-taking factor score showed higher discrimination power, i.e. AUC for BDs, Bipolar I disorder, and Bipolar II disorder was 0.71, 0.67, and 0.75, respectively.

Conclusions

The HCL-32 could not adequately distinguish BD patients from the non-clinical adult population. However, the current study identified items of irritable/risk-taking factor of the scale that could be useful in screening BDs in the general population.
Literature
1.
Maj M, Akiskal HS, Lopez-Ibor JJ, Sartorius N. Classification, diagnosis and boundaries of bipolar disorders. In: Bipolar disorder. London: Wiley; 2002. p. 1–52.CrossRef
2.
Scott J: Overcoming mood swings: A self-help guide using cognitive behavioural techniques. London: Constable & Robinson Ltd; 2001. p. 3-39.
3.
Baldessarini R, Bolzani L, Cruz N, Jones P, Lai M, Lepri B, Perez J, Salvatore P, Tohen M, Tondo L. Onset-age of bipolar disorders at six international sites. J Affect Disord. 2010;121(1):143–6.CrossRefPubMed
4.
Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64(2):161–74.CrossRefPubMed
5.
Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE, Lewis L, McElroy SL, Post RM, Rapport DJ. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873–5.CrossRefPubMed
6.
Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, Skeppar P, Vieta E, Scott J. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005;88(2):217–33.CrossRefPubMed
7.
Carta MG, Hardoy MC, Cadeddu M, Murru A, Campus A, Morosini PL, Gamma A, Angst J. The accuracy of the Italian version of the Hypomania Checklist (HCL-32) for the screening of bipolar disorders and comparison with the Mood Disorder Questionnaire (MDQ) in a clinical sample. Clin Pract Epidemiol Ment Health. 2006;2(1):2.CrossRefPubMedPubMedCentral
8.
Forty L, Smith D, Jones L, Jones I, Caesar S, Fraser C, Gordon-Smith K, Craddock N. Identifying hypomanic features in major depressive disorder using the hypomania checklist (HCL-32). J Affect Disord. 2009;114(1):68–73.CrossRefPubMed
9.
Yang HC, Xiang YT, Liu TB, Han R, Wang G, Hu C, Li LJ, Wang XP, Peng HJ, Si TM, et al. Hypomanic symptoms assessed by the HCL-32 in patients with major depressive disorder: a multicenter trial across China. J Affect Disord. 2012;143(1-3):203–7.CrossRefPubMed
10.
Angst J, Marneros A. Bipolarity from ancient to modern times: conception, birth and rebirth. J Affect Disord. 2001;67(1):3–19.CrossRefPubMed
11.
Forty L, Jones L, Jones I, Smith DJ, Caesar S, Fraser C, Gordon‐Smith K, Hyde S, Craddock N. Polarity at illness onset in bipolar I disorder and clinical course of illness. Bipolar Disord. 2009;11(1):82–8.CrossRefPubMed
12.
Have M, Vollebergh W, Bijl R, Nolen WA. Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord. 2002;68(2):203–13.CrossRefPubMed
13.
Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11(3):225–55.CrossRefPubMed
14.
Vieta E, Phillips ML. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull. 2007;33(4):886–92.CrossRefPubMedPubMedCentral
15.
Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rössler W. Diagnostic issues in bipolar disorder. Eur Neuropsychopharmacol. 2003;13:43–50.CrossRef
16.
Bae M, Lee K, Baek JH, Kim JS, Cho Y, Ryu S, Ha K, Hong KS. Lifetime experiences of hypomanic symptoms are associated with delayed and irregular sleep–wake cycle and seasonality in non-clinical adult samples. Compr Psychiatry. 2014;55(5):1111–5.CrossRefPubMed
17.
Tafalla M, Sanchez-Moreno J, Diez T, Vieta E. Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode. J Affect Disord. 2009;114(1):299–304.CrossRefPubMed
18.
Soares OT, Moreno DH, Moura EC, Angst J, Moreno RA. Reliability and validity of a Brazilian version of the Hypomania Checklist (HCL-32) compared to the Mood Disorder Questionnaire (MDQ). Rev Bras Psiquiatr. 2010;32(4):416–23.CrossRefPubMed
19.
Meyer TD, Hammelstein P, Nilsson L-G, Skeppar P, Adolfsson R, Angst J. The Hypomania Checklist (HCL-32): its factorial structure and association to indices of impairment in German and Swedish nonclinical samples. Compr Psychiatry. 2007;48(1):79–87.CrossRefPubMed
20.
Oh M, Angst J, Sung T, Lee E, Hong K, Lee D. Reliability and validity of the hypomania symptom checklist-32 in Korea. Korean J Clin Psychol. 2009;28:321–38.CrossRef
21.
An D, Hong KS, Kim J-H. Exploratory factor analysis and confirmatory factor analysis of the Korean version of Hypomania Checklist-32. Psychiatry Investig. 2011;8(4):334–9.CrossRefPubMedPubMedCentral
22.
23.
24.
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, Müller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12(1):77.CrossRefPubMedPubMedCentral
25.
Dabney A, Storey JD, Warnes G. Q-value estimation for false discovery rate control. Medicine. 2004;344:539–48.
26.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289–300.
27.
Ferrari AJ, Baxter AJ, Whiteford HA. A systematic review of the global distribution and availability of prevalence data for bipolar disorder. J Affect Disord. 2011;134(1):1–13.CrossRefPubMed
28.
Cerimele JM, Chwastiak LA, Dodson S, Katon WJ. The prevalence of bipolar disorder in general primary care samples: a systematic review. Gen Hosp Psychiatry. 2014;36(1):19–25.CrossRefPubMed
29.
Hidalgo-Mazzei D, Mateu A, Undurraga J, Rosa AR, Pacchiarotti I, del Mar Bonnin C, Sánchez-Moreno J, Colom F, Vieta E. e-HCL-32: a useful, valid and user friendly tool in the screening of bipolar II disorder. Compr Psychiatry. 2015;56:283–8.
30.
Feng Y, Xiang Y-T, Huang W, Wang G, Feng L, Tian T-F, Geng Y, Ungvari GS, Chiu HF, Ada W . The 33-item Hypomania Checklist (HCL-33): A new self-completed screening instrument for bipolar disorder. J Affect Disord. 2016;190:214–20.CrossRefPubMed
31.
Holtmann M, Pörtner F, Duketis E, Flechtner H-H, Angst J, Lehmkuhl G. Validation of the Hypomania Checklist (HCL-32) in a nonclinical sample of German adolescents. J Adolesc. 2009;32(5):1075–88.CrossRefPubMed
32.
Wu Y-S, Angst J, Ou C-S, Chen H-C, Lu R-B. Validation of the Chinese version of the Hypomania Checklist (HCL-32) as an instrument for detecting hypo (mania) in patients with mood disorders. J Affect Disord. 2008;106(1-2):133–43.CrossRefPubMed
33.
Meyer TD, Bernhard B, Born C, Fuhr K, Gerber S, Schaerer L, Langosch JM, Pfennig A, Sasse J, Scheiter S. The Hypomania Checklist-32 and the Mood Disorder Questionnaire as screening tools—going beyond samples of purely mood-disordered patients. J Affect Disord. 2011;128(3):291–8.CrossRefPubMed
34.
Vieta E, Sanchez-Moreno J, Bulbena A, Chamorro L, Ramos JL, Artal J, Perez F, Oliveras MA, Valle J, Lahuerta J, et al. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32). J Affect Disord. 2007;101(1-3):43–55.CrossRefPubMed
35.
Brand S, Gerber M, Pühse U, Holsboer-Trachsler E. ‘Bright side’and ‘dark side’hypomania are associated with differences in psychological functioning, sleep and physical activity in a non-clinical sample of young adults. J Affect Disord. 2011;131(1):68–78.CrossRefPubMed
Metadata
Title
Investigation of the clinical utility of the hypomania checklist 32 (HCL-32) for the screening of bipolar disorders in the non-clinical adult population
Authors
Kounseok Lee
Hyeji Oh
Eun-Ho Lee
Joo Hyun Kim
Ji-Hae Kim
Kyung Sue Hong
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2016
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-016-0831-8

Other articles of this Issue 1/2016

BMC Psychiatry 1/2016 Go to the issue

Research article

Personality differences in early versus late suicide attempters

Research article

The mental health status of ethnocultural minorities in Ontario and their mental health care

Study protocol

Impact of peer-led quality improvement networks on quality of inpatient mental health care: study protocol for a cluster randomized controlled trial

Research article

Validity assessment of the symptom checklist SCL-90-R and shortened versions for the general population in Ukraine

Research article

The effects of living environment on disaster workers: a one–year longitudinal study

Case report

Experience of the use of Ketamine to manage opioid withdrawal in an addicted woman: a case report